Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (111-120 of 212) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|July 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial designKristine Broglio, Lale Kostakoglu, Carol Ward, et al.
Cancer Treatment Reviews|April 3, 2007
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysisAlexander Greb, Julia Bohlius, Sven Trelle, et al.
Blood|January 12, 2012
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPPatrizia Pregno, Annalisa Chiappella, Marilena Bellò, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Hematological Oncology|March 8, 2018
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleedingGiuseppe Boriani, Paolo Corradini, Antonio Cuneo, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Haematologica|June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trialUmberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
Tropical Medicine and Infectious Disease|June 27, 2023
<i>Strongyloides</i> spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin LymphomaTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Clinical Lymphoma|July 13, 2004
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphomaAlessandro Levis, Daniela Pietrasanta, Laura Godio, et al.
Tropical Medicine and Infectious Disease|July 28, 2023
Overlapping Infection by <i>Strongyloides</i> spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the LiteratureTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Pageof 22

Showing results (111-120 of 212) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|July 11, 2022
PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial designKristine Broglio, Lale Kostakoglu, Carol Ward, et al.
Cancer Treatment Reviews|April 3, 2007
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma - results of a comprehensive meta-analysisAlexander Greb, Julia Bohlius, Sven Trelle, et al.
Blood|January 12, 2012
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOPPatrizia Pregno, Annalisa Chiappella, Marilena Bellò, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Hematological Oncology|March 8, 2018
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleedingGiuseppe Boriani, Paolo Corradini, Antonio Cuneo, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Haematologica|June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trialUmberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
Tropical Medicine and Infectious Disease|June 27, 2023
<i>Strongyloides</i> spp. and Cytomegalovirus Co-Infection in Patient Affected by Non-Hodgkin LymphomaTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Clinical Lymphoma|July 13, 2004
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphomaAlessandro Levis, Daniela Pietrasanta, Laura Godio, et al.
Tropical Medicine and Infectious Disease|July 28, 2023
Overlapping Infection by <i>Strongyloides</i> spp. and Cytomegalovirus in the Immunocompromised Host: A Comprehensive Review of the LiteratureTommaso Lupia, Elena Crisà, Alberto Gaviraghi, et al.
Pageof 22